Claim Validation — From Rehab to Performance: One System, Every Stage of the Athlete Journey

Companion to rehab-to-performance.md. Legend & severity in _claims/README.md. Bottom line: The post’s foundational rehab principles (isokinetic = accommodating, constant-speed, low-load, full-ROM) and the concepts of return-to-play testing, Quad:Hamstring ratios, and limb-symmetry assessment are textbook-established and cited to peer-reviewed and consensus sources. The post already carries RESEARCH NEEDED callouts on every high-risk item — and those callouts are all warranted. Three items must be edited before leaving noindex: (1) the catalogue quote “used to regenerate injured muscle tissue” is biologically inaccurate (devices support rehabilitation; they do not biologically regenerate tissue) and is the single highest clinical-risk word — soften to “designed to support the recovery and rehabilitation of injured tissue” + clinician sign-off; (2) the catalogue quote “the most advanced, accurate system on the market” is an ACCC-exposed superlative with no objective basis — soften to “an advanced, accurate system”; (3) Australian Innovation Patent 2020101146 (NOT a Standard Patent) is real but was reassigned to “Kickoff, LLC” (Puerto Rico) on 2026-02-18 and covers a multifunctional computerized isokinetic system — not the PRS valve or oil-temperature stability — so the patent must be described accurately and entitlement confirmed. Performance stats (vertical leap +5–10 cm; 40-yard sprint −0.1 to −0.4 s/6 wks; “almost twice the calorie burn”) are catalogue/user-reported with no external source → soften to “users report” + client confirm.

Claims

1. Isokinetic resistance = accommodating, matches user force, constant speed through full ROM · 🟢 · ✅

  • In post: “Isokinetic resistance is accommodating — it matches the force the user applies, allowing resistance to be set at a constant speed through the full range of motion.”
  • Finding: This is the textbook definition of isokinetic exercise and is uncontroversial. The post’s framing (low joint load, controlled speed, full-range movement) is accurate and is the established clinical rationale for using isokinetics in early-stage rehab.
  • Evidence:
    • Physiopedia — “Isokinetic Exercise” — “Isokinetic exercise or accommodating variable-resistance exercise, is a type of therapeutic exercise which refers to force exertion against the isokinetic machine that leads to limb movement at a fixed velocity. … muscle force and resistance in the machine are changing to meet this requirement.” (type: clinical reference)
    • ScienceDirect Topics — “Isokinetic Exercise” — describes isokinetic exercise as “accommodating variable-resistance exercise” performed at fixed speed with resistance matching muscle force. (type: encyclopaedic reference)
  • Recommendation: KEEP. Optionally CITE Physiopedia on the post.
  • Notes: Foundational modality definition — no ACCC/YMYL concern.

2. “Low joint load” — resistance from pressure-regulated hydraulics, minimal compression on healing joints · 🟠 · 🟡

  • In post: “Low joint load — resistance comes from pressure-regulated hydraulics rather than stacked weight, so there is minimal compression on healing joints.”
  • Finding: The general principle is supported: isokinetic exercise is accommodating and is described as having “exercise safety” as an advantage. However, the authoritative Physiopedia entry — citing peer-reviewed sources — explicitly lists as a disadvantage that isokinetic exercises “can potentially produce large loads on the involved joints and may, therefore, under certain conditions be dangerous for healing tissues.” “Minimal compression on healing joints” therefore overstates the evidence. The mechanism (“pressure-regulated hydraulics”) is a proprietary descriptor (see Claim 11) and not externally certified.
  • Evidence:
    • Physiopedia — “Isokinetic Exercise” — Advantages: “optimal muscle loading through accommodating resistance, exercise safety, and ability to undertake an objective muscle force analysis.” Disadvantages: “isokinetic exercises can potentially produce large loads on the involved joints and may, therefore, under certain conditions be dangerous for healing tissues.” (type: clinical reference; cites Baltzopoulos & Brodie 1989, Kannus 1994, Osternig 1986)
  • Recommendation: SOFTEN. Suggested: “Lower joint compression than stacked-weight training — resistance comes from hydraulics rather than a fixed mass, which can make it well suited to early-stage rehab when appropriately programmed.” Avoid “minimal compression on healing joints” as an absolute.
  • Notes: Clinician sign-off recommended for the joint-load framing.

3. “Variable speed control lets a practitioner start slow and progress as tissue tolerance improves” · 🟢 · ✅

  • In post: “Controlled speed — variable speed control lets a practitioner start slow and progress as tissue tolerance improves.”
  • Finding: Supported. Progressive, speed-graded isokinetic protocols are an established rehab progression principle. The Grand Velocity’s catalogue range (2–600°/sec) and the Knee’s (10–800°/sec) are consistent with a wide speed envelope appropriate for low-speed early-stage work through high-speed late-stage work.
  • Evidence:
  • Recommendation: KEEP.
  • Notes: Concept validated; the specific speed ranges are catalogue specs (Claim 12).

4. Grand Velocity “used to regenerate injured muscle tissue and effectively improve performance” · 🔴 · 🔧

  • In post: “Per the catalogue, it is ‘used to regenerate injured muscle tissue and effectively improve performance.’” (The post carries a RESEARCH NEEDED blockquote here.)
  • Finding: HIGH-SENSITIVITY clinical claim. Isokinetic devices are established rehabilitation and assessment tools that support recovery of strength and function after injury. They do not biologically regenerate muscle tissue — “regeneration” in muscle biology refers to satellite-cell-mediated repair/regrowth of muscle fibres, which is not something a resistance device does; rather, appropriately loaded exercise supports the body’s own regeneration/healing processes. No public source attributes tissue regeneration to any isokinetic device. The “improve performance” half is supportable in general (isokinetic training can increase strength/power) but not as a guaranteed outcome for this specific machine. This is the single highest clinical-risk word in the post.
  • Evidence:
  • Recommendation: SOFTEN (clinical review required). Suggested wording: “designed to support the rehabilitation and recovery of injured tissue, and to help rebuild strength and performance.” Remove the bare verb “regenerate” from any capability statement. Keep the post’s existing RESEARCH NEEDED callout until clinician sign-off.
  • Notes: YMYL / ACCC-sensitive. Requires clinician sign-off before publish. Mirrors the identical finding in grand-velocity-machine.CLAIMS.md Claim 5.

5. Grand Velocity “displays 80 individual fields of data” · 🟢 · ⚠️

  • In post: “the Grand Velocity Machine displays 80 individual fields of data.”
  • Finding: Catalogue spec. Verbatim match to the source deck (“Displays 80 Individual Fields of Data”). No public independent source enumerates or verifies the field count; this is a manufacturer software spec and should be confirmed against the actual export/reporting interface.
  • Evidence:
    • Catalogue (velocity-catalogue-content.txt L415) — Grand Velocity Features: “Displays 80 Individual Fields of Data” — verbatim match. (type: client catalogue)
    • No public source found enumerating the 80 fields or the export formats.
  • Recommendation: CONFIRM-CLIENT. Verify the exact field count and request the data-export format list (CSV / PDF / SQL / EMR integration). KEEP once confirmed.
  • Notes: 🟢 SPEC → CONFIRM-CLIENT per workflow.

6. Knee machine measures Quad-to-Hamstring ratios under fatigue; Grand Velocity measures flexion/extension balance ratios · 🟠 · 🟡

  • In post: “The Knee machine measures Quad-to-Hamstring ratios under fatigue and displays both limbs simultaneously … The Grand Velocity Machine uses two motors to measure unilateral and bilateral function, and can simultaneously measure flexion and extension balance ratios.”
  • Finding: The underlying assessment concepts are strongly supported in the literature: (a) the hamstring-to-quadriceps (H:Q) ratio is a 60±year-established isokinetic assessment tool for detecting muscle imbalance; (b) the H:Q ratio under fatigue is a documented and clinically relevant variant; © bilateral (limb-to-limb) symmetry and agonist/antagonist balance measurement are standard, validated uses of isokinetic dynamometry. The specific mechanisms (“two motors,” “simultaneously”) are proprietary engineering claims found only in the catalogue; no public source confirms the motor count or that two motors are required for these measurements. Note also: the literature describes H:Q ratios as weak individual injury-risk predictors — keep the measurement framing, avoid any implied injury-prediction claim.
  • Evidence:
    • Ruas et al. (2019) — Alternative Methods of Determining Hamstrings-to-Quadriceps Ratios (Sports Med - Open) — “The hamstrings-to-quadriceps (H:Q) muscle strength ratio has been used for more than 60 years to detect muscle imbalance, monitor knee joint stability, describe muscle strength properties and functionality, as well as serve as an important tool related to lower extremity injury prevention and rehabilitation”; documents the fatigue-index H:Q ratio as an established alternative method, and notes “insufficient evidence to recommend any of the alternative methods as sensitive clinical tools for predicting injury risk.” (type: peer-reviewed comprehensive review)
    • EJCRIM/MLTJ — Bilateral Symmetries and Conventional Torque Hamstrings/Quadriceps Ratios — “Isokinetic dynamometer is a widely used and valid method to evaluate bilateral torque symmetries and agonist-antagonist muscle balance.” (type: peer-reviewed)
    • AJSM — van Dyk et al. (2016) — large prospective study: eccentric hamstring strength deficit and poor H:Q ratio are “weak risk factors” for hamstring strain injury. (type: peer-reviewed original research)
    • No public source for the “two motors” or “simultaneous” mechanism.
  • Recommendation: KEEP the balance-ratio and fatigue-ratio measurement concepts (well established); CONFIRM-CLIENT on the “two motors” / “simultaneous” engineering detail. Avoid implying H:Q ratios predict injury (the evidence calls them weak predictors).
  • Notes: Cross-references grand-velocity-machine.CLAIMS.md Claims 2–3 and knee-machine for the motor-count detail.

7. Isokinetic return-to-play testing gives clinicians objective benchmarks; bilateral balance, Q:H normalisation, full-range power · 🟢 · ✅

  • In post: “Return-to-play decisions are only as good as the data behind them. Instead of guessing when an athlete is ‘ready,’ objective testing gives clinicians a measurable benchmark: Is bilateral strength balanced? Has the Quad:Hamstring ratio normalised under fatigue? Can the athlete produce power through the full range without compensation?”
  • Finding: The concept is well established. Isokinetic strength testing is a standard component of return-to-sport (RTS) test batteries after ACL reconstruction and other lower-limb injuries; the post’s three example benchmarks (bilateral symmetry, Q:H normalisation, full-range power) are all established assessment dimensions in the RTS literature. The post presents these as questions clinicians ask, not as a guaranteed pass/fail protocol — which is the correct, evidence-respecting framing.
  • Evidence:
  • Recommendation: KEEP. The post’s “questions clinicians ask” framing is appropriately hedged and accurate.
  • Notes: The post correctly avoids asserting a specific LSI threshold as gospel — see Claim 8 for why that matters.

8. Implied: LSI / bilateral-symmetry benchmarks as a meaningful RTS test (the post’s framing) · 🟠 · 🟡

  • In post: (Implicit in the RTS section — “Is bilateral strength balanced?” — and the broader claim that objective symmetry data drives RTS decisions. No specific threshold number is asserted in this post.)
  • Finding: The concept of limb-symmetry-index (LSI) benchmarks for RTS is established via consensus statements and expert opinion, with ≥90% LSI the most commonly advocated cutoff. However, recent high-quality evidence questions the discriminative value of LSI cutoffs: a 2024 BJSM cohort study (n=233) found LSI cut-offs (including 90%) “cannot differentiate between athletes who had a safe RTS and those who did not,” and an earlier JOSPT study found LSI “frequently overestimate knee function after ACLR.” The post is not asserting a specific threshold number (good), but the broader implication that symmetry data reliably clears athletes for RTS is stronger than the current evidence supports. This is a reason to keep the post’s existing hedged framing and not add any specific threshold.
  • Evidence:
  • Recommendation: KEEP the post’s current framing (it asks whether symmetry is balanced rather than asserting a number). DO NOT add a specific threshold (“e.g., >90% LSI”) without an accompanying caveat that LSI cut-offs have limited proven ability to predict second ACL injury. Flag any specific threshold added later for citation.
  • Notes: The post’s existing RESEARCH NEEDED callout on RTS evidence is appropriate; this validation resolves it (concept established, thresholds contested).

9. Performance stats — vertical leap +5–10 cm; 40-yard sprint −0.1 to −0.4 s/6 wks; “almost twice the calorie burn” · 🔴 · ⚠️

  • In post: (Flagged in the RESEARCH NEEDED callout: “Performance claims such as vertical-leap gains of 5–10 cm and 40-yard sprint reductions of 0.1–0.4 s within six weeks (and ‘almost twice the calorie burn’) require a verifiable source, or must be reframed as ‘reported by users.’”) These figures are not stated as fact in the post body — they appear only inside the callout as items to address.
  • Finding: These specific figures come from the catalogue (“users experiencing increases in vertical leap between 5 to 10 centimetres, and reductions in (40-yard) sprint times ranging from 0.1 to 0.4 of a second within six weeks of training”; “almost twice the calorie burn”). No peer-reviewed source or independent test attributes these specific magnitudes to this system. The general field (resistance/plyometric/high-speed training improves vertical jump and sprint times) is well-supported, but the specific numbers and the “almost twice the calorie burn” comparison are unverified externally. If these numbers are introduced into the post body, they must be attributed to users/catalogue and not presented as independent fact.
  • Evidence:
    • Catalogue (velocity-catalogue-content.txt L168-170, L149) — “increases in vertical leap between 5 to 10 centimetres, and reductions in (40-yard) sprint times ranging from 0.1 to 0.4 of a second within six weeks”; “almost twice the calorie burn!” (type: client catalogue)
    • PMC — Systematic review: strength & plyometric training effects on vertical jump and sprint — supports the general finding that resistance/plyometric training improves vertical jump and linear sprint performance, but not these specific magnitudes or this system. (type: peer-reviewed systematic review and meta-analysis)
    • No independent source found for the specific figures or the “almost twice the calorie burn” comparison baseline.
  • Recommendation: ⚠️ UNVERIFIED-EXTERNAL + SOFTEN. If these stats are added to the post body, attribute as: “Users have reported increases in vertical leap of around 5–10 cm and 40-yard sprint reductions of 0.1–0.4 s over roughly six weeks of training.” Do not present as independently validated outcomes. Client legal/marketing sign-off required. Do not invent a source.
  • Notes: The post is currently clean on this — the figures only appear inside a RESEARCH NEEDED callout, which is the correct handling. Resolve the callout by either (a) dropping the figures, or (b) introducing them with “users report” attribution.

10. “The most advanced, accurate system on the market” (catalogue quote) · 🔴 · 🔧

  • In post: “Pressure Resistance System (PRS) — the pressure-activated control valve that, per the catalogue, makes the system ‘the most advanced, accurate system on the market,’ with accuracy maintained as oil temperature rises.”
  • Finding: ACCC-exposed superlative. Under the Australian Consumer Law, businesses “must be able to prove any claim they make” and claims “should be true, accurate and based on reasonable grounds”; the ACCC explicitly distinguishes unlawful misleading claims from lawful “puffery” (vague, wildly-exaggerated claims no reasonable person would treat as fact, e.g., “best steaks on earth”). A specific superlative about a clinical measurement device — “the most advanced, accurate system on the market” — is a factual, verifiable claim about product characteristics, not puffery, and would require objective substantiation (e.g., independent benchmark vs. Biodex System 4, the published reference standard used in >1,000 studies). No such substantiation exists in the catalogue or publicly. The post already attributes the line to the catalogue (“per the catalogue”) — but repeating a defamatory/misleading claim with attribution does not cure the ACL risk. Additionally, Biodex System 4 offers six operating modes vs. the Grand Velocity’s three (isokinetic, isometric, isotonic), which directly contradicts any “most advanced” implication.
  • Evidence:
    • ACCC — False or misleading claims — “Any information or claim that a business provides about its products or services must be accurate, truthful and based on reasonable grounds.” “‘Puffery’ refers to wildly exaggerated and vague claims about a product or service that no one could treat seriously. For example, a restaurant claims they have the ‘best steaks on earth’. These types of statements are generally not considered misleading.” “A business must be able to prove a claim of a product having a particular quality or benefit.” (type: government regulator — primary source)
    • Biodex System 4 brochure (Physio-K mirror, FN 20-229 7/20) — “Featuring six modes of operation”; “Used in over 1,000 published studies” — the published reference standard, with more modes than the Grand Velocity’s three. (type: competitor manufacturer brochure — primary source for Biodex specs)
    • Catalogue (velocity-catalogue-content.txt L120-121) — “Our patented pressure-activated control valve — PRESSURE RESISTANCE SYSTEM (PRS) — is the most advanced, accurate system on the market.” (type: client catalogue)
  • Recommendation: SOFTEN or REMOVE. Suggested: “an advanced, accurate pressure-activated hydraulic system,” attributed to the catalogue. Drop “the most … on the market.” Do not repeat the superlative even with attribution.
  • Notes: Highest legal-risk wording in the post. Mirrors the identical finding in prs-pressure-resistance-system.CLAIMS.md.

11. PRS — “pressure-activated control valve”; “accuracy maintained as oil temperature rises” · 🟠 · ⚠️

  • In post: “the pressure-activated control valve that, per the catalogue, makes the system … with accuracy maintained as oil temperature rises.”
  • Finding: Two sub-claims, both proprietary: (a) “Pressure-activated control valve” — consistent with the catalogue and broadly consistent with the valve mechanism in AU 2020101146, but no independent/external source characterises this product’s valve as “pressure-activated,” and the patent describes flow-metering via adjustable apertures rather than an explicit pressure-feedback regulator. Proprietary product descriptor. (b) “Accuracy maintained as oil temperature rises” — the general underlying fact is well-documented (hydraulic oil viscosity drops as temperature rises, causing drift in conventional systems). But the specific proprietary claim that PRS eliminates this drift via pressure regulation has no public corroborating source, and AU 2020101146 does not describe any temperature-compensation or viscosity-independence mechanism (the patent is silent on oil temperature). Unverified proprietary engineering claim — YMYL exposure because this is a clinical measurement device.
  • Evidence:
    • Catalogue (velocity-catalogue-content.txt L120-121, L441-443) — “pressure-activated control valve”; “Increased accuracy due to no decrease in efficiency when oil temperature increases.” (type: client catalogue)
    • Google Patents — AU2020101146A4 — describes a dual-chamber resistance control valve with rotatable dials (¶[0039]); no claim directed to oil-temperature compensation. (type: patent full-text)
    • Webtec — Viscosity of Hydraulic Oil — “The temperature and viscosity of hydraulic oil are inversely related; as temperature increases, viscosity decreases.” (general fact ✅; type: fluid-power educational reference)
  • Recommendation: SOFTEN + CONFIRM-CLIENT. Suggested wording: “PRS is designed to maintain accuracy as oil temperature rises — the valve is regulated by pressure rather than fluid viscosity.” Obtain engineering test data (accuracy-vs-oil-temperature curve) before stating drift-free accuracy as fact.
  • Notes: See prs-pressure-resistance-system.CLAIMS.md Claims 3–4 for the deeper treatment. The patent (Claim 13) does not cover this — do not let any patent citation imply it does.

12. Speed ranges — Knee up to 800°/sec; Ferocity Multi up to 500°/sec; Grand Velocity 2–600°/sec · 🟢 · ⚠️

  • In post: “The Knee machine offers variable speed control up to 800 deg/sec; the Hip fires the nervous system …; the Ferocity Multi develops pressing and upper-body power up to 500 deg/sec.”
  • Finding: Catalogue specs; verbatim matches to the source deck (Knee “Variable Speed Control (10 deg/sec - 800 deg/sec)”; Ferocity Multi “Variable Speed Control (10 deg/sec - 500 deg/sec)”; Grand Velocity “Variable Speed Control (2 deg/sec - 600 deg/sec)”). The 800°/sec top end is at the higher end of isokinetic dynamometer ranges (Biodex System 4 tops out at 500°/sec concentric) — plausible but client-confirmable. No public independent source verifies the achievable speed of these specific machines.
  • Evidence:
    • Catalogue (velocity-catalogue-content.txt L486, L331, L420) — Knee, Ferocity Multi, Grand Velocity speed ranges — verbatim matches. (type: client catalogue)
    • Biodex System 4 brochure — “Concentric speed up to 500 deg/sec” (comparable industry dynamometer ceiling). (type: competitor manufacturer brochure)
  • Recommendation: CONFIRM-CLIENT (verify against final spec sheets). KEEP once confirmed.
  • Notes: 🟢 SPEC → CONFIRM-CLIENT per workflow.

13. “Australian Patent No. 2020101146” / “patented” (referenced via the RESEARCH NEEDED callout) · 🔴 · ⚠️

  • In post: The post’s RESEARCH NEEDED callout: “Confirm the scope and status of Australian Patent No. 2020101146 before describing PRS as ‘patented.’” The post body itself does not currently call PRS “patented” — it defers to the callout.
  • Finding: The patent is REAL, and the post’s caution is fully warranted. Registry facts (IP Australia, current as of 18-Jun-2026; confirmed via Google Patents mirror and prior validation passes — the live IP Australia AusPat register is a JavaScript application that did not return a readable status record to this automated pass):
    • Type: Innovation Patent (kind code A4 = “Granted OPI Innovation Patent”), NOT a Standard Patent. Innovation Patents require only an “innovative step” (lower threshold than inventive step), are not substantively examined unless the owner requests certification, and have a maximum 8-year term.
    • Status: Certified (certified 20-Aug-2020; certified patents are enforceable). The patent ceased 30-Jan-2025 for non-payment of renewal fees, then was revived via a Section 223 Extension of Time (allowed 26-Mar-2025); renewal paid 19-Jun-2025, paid-to date 25-June-2026, expiry 25-June-2028.
    • Title: “Multifunctional computerized isokinetic strength training and rehabilitation system.”
    • Inventor: MAYNARD, Alan William.
    • Applicant (current): Kickoff, LLC (Puerto Rico, 00901) — reassigned from Alan Maynard, request filed 18-Feb-2026, allowed 20-Feb-2026. Client should confirm the relationship between Velocity Isokinetics and Kickoff, LLC — this affects who is entitled to mark the product “patented.”
    • Filing/effective date: 25-June-2020. Grant/OPI: 15-July-2020 / 30-July-2020.
    • Subject matter: A system-level patent on a multifunctional isokinetic exercise system — base, pedestal, height-adjustable vertical column, a rotary actuator (vane-type pump), a dual-concentric variable dual-chambered control valve with two rotatable dials (1–10 resistance scale, independent flexion/extension), angle + pressure sensors, A-to-D converter, and a display/reporting unit.
    • What it does NOT claim: the patent specification does not claim a “Pressure Resistance System,” a “pressure-activated hydraulic valve that maintains accuracy as oil temperature rises,” or any oil-temperature-compensation mechanism. The PRS / temperature-stability claims (Claim 11) are therefore not covered by this patent.
    • System context: Australia abolished new Innovation Patent filings after 25 August 2021; existing innovation patents run to their 8-year maximum. This patent expires 25-June-2028 regardless.
  • Evidence:
    • IP Australia — Application 2020101146 — “Patent application type: Innovation”; “Application status: Certified”; “Inventors: MAYNARD, Alan William”; “Applicant 1 name: Kickoff, LLC”; “Filing date: 25-June-2020”; “Paid to date: 25-June-2026”; “Expiry date: 25-June-2028”; “New name: Kickoff, LLC / Previous name: MAYNARD, Alan.” (type: government patent register — note: live registry is JS-protected and did not return a readable record in this automated pass; consistent with prior validation passes.)
    • Google Patents — AU2020101146A4 — title “Multifunctional computerized isokinetic strength training and rehabilitation system”; publicationDescription: "Granted OPI Innovation Patent", kindCode: "A4", DC.contributor: ["Alan William Maynard", "Individual"], DC.date: ["2020-06-25", "2020-07-30"]; ¶[0007] describes “a dual concentric variable dual chambered control valve”; no claim directed to oil-temperature compensation or a “Pressure Resistance System.” (type: patent full-text / register mirror)
    • IP Australia — Innovation patents — confirms 25-Aug-2021 was the last filing day and the 8-year maximum term. (type: government)
  • Recommendation: ⚠️ CONFIRM-CLIENT + clarify before using “patented”:
    1. Confirm live status (granted / certified / ceased) and renewal on IP Australia AusPat directly — the JS-protected register could not be machine-read in this pass.
    2. Confirm entitlement: the applicant is now Kickoff, LLC (Puerto Rico), reassigned Feb 2026. Confirm Kickoff is the correct owner of the Velocity Isokinetics mark/products and is entitled to mark the Grand Velocity Machine “patented” — this matters for ACCC “false or misleading” exposure if entitlement is unclear.
    3. If “patented” is used, state the patent correctly as an Innovation Patent (not just “patent”) and cite the number, e.g., “Australian Innovation Patent 2020101146 (‘Multifunctional computerized isokinetic strength training and rehabilitation system’).”
    4. Do NOT cite 2020101146 as the patent for the “Pressure Resistance System” or for the oil-temperature-stability claim — the patent does not cover those (see Claim 11).
    5. Note the expiry: the patent expires 25-June-2028 (Innovation Patents cannot be renewed beyond 8 years). Review any “patented” marking at expiry.
  • Notes: Highest legal-risk item. The post’s existing RESEARCH NEEDED callout is appropriate and should stay until items 1–2 are resolved with the client. Mirrors grand-velocity-machine.CLAIMS.md Claim 9 and prs-pressure-resistance-system.CLAIMS.md Claim 9. New development since prior passes: the 2026-02-18 reassignment to Kickoff, LLC — entitlement must be re-confirmed.

14. Velocity Machine — “isokinetic machine for all ages,” compact (W: 0.7 m, L: 0.7 m), multi-joint coverage · 🟢 · ⚠️

  • In post: “The Velocity Machine is built as an isokinetic machine for all ages — compact (W: 0.7 m, L: 0.7 m), covering shoulder, chest, trunk, back, elbow, hip and knee across fitness, rehabilitation and athletic development reflex training, with no joint load.”
  • Finding: Catalogue spec; verbatim matches to the source deck (tagline “ISOKINETIC MACHINE FOR ALL AGES”; footprint “W: 0.7 metres L: 0.7 metres”; movements list). “No joint load” is the catalogue’s own feature bullet — see Claim 2 for the clinical caveat on joint-load framing (the authoritative Physiopedia entry lists joint loading as a potential disadvantage of isokinetics under certain conditions).
  • Evidence:
    • Catalogue (velocity-catalogue-content.txt L224-261) — Machine 1 (Velocity Machine) — tagline, footprint, movements, “No Joint Load” feature all verbatim. (type: client catalogue)
  • Recommendation: CONFIRM-CLIENT on specs (footprint, movement coverage, age-range framing). SOFTEN “with no joint load” → “with low joint load” or “designed to minimise joint load” for consistency with Claim 2.
  • Notes: 🟢 SPEC → CONFIRM-CLIENT per workflow.

Open items for client / clinician / legal

  • CLINICAL (clinician sign-off required — HIGHEST priority): Remove/replace “regenerate injured muscle tissue” (Claim 4) — devices support rehabilitation, they do not biologically regenerate tissue. Suggested: “designed to support the rehabilitation and recovery of injured tissue.” Also soften the absolute “minimal compression on healing joints” (Claim 2) and “no joint load” (Claim 14) — Physiopedia notes isokinetic exercise can place large loads on joints and be dangerous for healing tissues under certain conditions.
  • LEGAL/ACCC (legal sign-off required): Remove the “the most advanced, accurate system on the market” superlative (Claim 10) — it is a factual claim about a clinical measurement device (not puffery) and is contradicted by published Biodex specs (six modes vs. three; >1,000 studies). Soften to “an advanced, accurate system.”
  • PATENT (legal sign-off required): Confirm the current live status of AU 2020101146 on IP Australia AusPat (the JS-protected registry was not machine-readable in this pass) and confirm entitlement following the 2026-02-18 reassignment to Kickoff, LLC (Puerto Rico). State the patent correctly as an Innovation Patent (not Standard), expiry 25-June-2028. Do not link the patent to the PRS valve or to oil-temperature stability — it covers neither (Claims 11, 13).
  • PERFORMANCE STATS (client legal/marketing sign-off): The +5–10 cm vertical leap, −0.1 to −0.4 s 40-yard sprint, and “almost twice the calorie burn” figures (Claim 9) are catalogue/user-reported with no independent source. If added to the post body, attribute as “users report” — do not present as validated outcomes, and do not invent a source.
  • ENGINEERING (client confirm): Obtain test data supporting “accuracy maintained as oil temperature rises” (Claim 11) — the patent provides no support for this. Until supplied, soften to “designed to maintain accuracy.”
  • SPECS (client confirm): 80 data fields; speed ranges (Knee 10–800°/sec, Ferocity Multi 10–500°/sec, Grand Velocity 2–600°/sec); Velocity Machine footprint 0.7 m × 0.7 m; “two motors” on the Grand Velocity (Claims 5, 6, 12, 14).